繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 眼科 >> 黄斑变性 >> 药品推荐 >> Ozurdex implant(地塞米松玻璃体内植入物)

Ozurdex implant(地塞米松玻璃体内植入物)

2018-08-31 04:41:47  作者:新特药房  来源:互联网  浏览次数:13  文字大小:【】【】【
简介:眼科新药Ozurdex(dexamethasone intravitreal implant)是一种以缓释、生物可降解的植入物,通过长期缓慢释放激素来抑制炎症,从而达到治疗糖尿病黄斑水肿的目的。Ozurdex长期有效,不需要每月注射。作用 ...

眼科新药Ozurdex(dexamethasone intravitreal implant)是一种以缓释、生物可降解的植入物,通过长期缓慢释放激素来抑制炎症,从而达到治疗糖尿病黄斑水肿的目的。Ozurdex长期有效,不需要每月注射。
作用机制
已显示地塞米松是一种皮质类固醇,通过抑制多种炎性细胞因子来抑制炎症,导致水肿,纤维蛋白沉积减少,毛细血管渗漏和炎性细胞迁移。
适应症和用法
OZURDEX®是一种皮质类固醇,适用于:
视网膜分支静脉阻塞(BRVO)或视网膜中央静脉阻塞(CRVO)后黄斑水肿的治疗。
治疗影响眼后节的非感染性葡萄膜炎
糖尿病性黄斑水肿的治疗。
剂量和给药
用于眼科玻璃体内注射。
玻璃体内注射过程应在受控无菌条件下进行。
玻璃体内注射后,应监测患者眼内压升高和眼内炎。
剂型和强度
在NOVADUR®固体聚合物药物输送系统中含有0.7mg地塞米松的玻璃体内植入物。
禁忌症
眼或眼周感染
青光眼
撕裂或破裂的晶状体后囊
过敏症
警告和注意事项
玻璃体内注射与眼内炎,眼睛炎症,眼内压升高和视网膜脱离有关。注射后应监测患者。
使用皮质类固醇可能会导致后囊下白内障,眼内压升高,青光眼,并可能增加由细菌,真菌或病毒引起的继发性眼部感染。
不良反应
在对照研究中,20-70%的患者报告的最常见的不良反应是白内障,眼内压升高和结膜出血。
包装提供/储存和处理
OZURDEX®(地塞米松玻璃体内植入物)0.7mg以1个一次性塑料涂药器提供在箔袋中。


OZURDEX(dexamethasone intravitreal implant)
OZURDEX(dexamethasone intravitreal implant) is a prescription medicine that is an implant injected into the eye (vitreous) and used:
To treat adults with diabetic macular edema
To treat adults with swelling of the macula (macular edema) following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO)
To treat adults with noninfectious inflammation of the uvea (uveitis) affecting the back segment of the eye
IMPORTANT SAFETY INFORMATION (continued)
When Not to Use OZURDEX® (continued)
OZURDEX® should not be used if you have glaucoma that has progressed to a cup-to-disc ratio of greater than 0.8.
OZURDEX® should not be used if you have a posterior lens capsule that is torn or ruptured.
OZURDEX® should not be used if you are allergic to any of its ingredients.
Warnings and Precautions
Injections into the vitreous in the eye, including those with OZURDEX®, are associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal detachments. Your eye doctor should monitor you regularly after the injection.
Use of corticosteroids including OZURDEX® may produce posterior subcapsular cataracts, increased eye pressure, glaucoma, and may increase the establishment of secondary eye infections due to bacteria, fungi, or viruses. Let your doctor know if you have a history of ocular herpes simplex as corticosteroids are not recommended in these patients.
Common Side Effects in Diabetic Macular Edema
The most common side effects reported in patients with diabetic macular edema include: cataract, increased eye pressure, conjunctival blood spot, reduced vision, inflammation of the conjunctiva, specks that float in the field of vision, swelling of the conjunctiva, dry eye, vitreous detachment, vitreous opacities, retinal aneurysm, foreign body sensation, corneal erosion, inflammation of the cornea, anterior chamber inflammation, retinal tear, drooping eyelid, high blood pressure, and bronchitis.
Common Side Effects in Retinal Vein Occlusion and Uveitis
The most common side effects reported in patients for retinal vein occlusion and uveitis include: increased eye pressure, conjunctival blood spot, eye pain, eye redness, ocular hypertension, cataract, vitreous detachment, and headache.
Patient Counseling Information
After repeated injections with OZURDEX®, a cataract may occur. If this occurs, your vision will decrease and you will need an operation to remove the cataract and restore your vision.You may develop increased eye pressure with OZURDEX® that will need to be managed with eye drops, and rarely, with surgery.
In the days following injection with OZURDEX®, you may be at risk for potential complications including in particular, but not limited to, the development of serious eye infection or increased eye pressure. If your eye becomes red, sensitive to light, painful, or develops a change in vision, you should seek immediate care from your eye doctor. You may experience temporary visual blurring after receiving an injection and should not drive or use machinery until your vision has resolved.
--------------------------------------------------------
注:以下产品是德国各厂家,购者以咨询为准
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
OZURDEX 700Mikrogramm 1ST
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松
生产厂家英文名:
Allergan Pharmaceuticals Ireland
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
Ozurdex 700Mikrogramm Implantat 1Stk
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松
生产厂家英文名:
Eurimpharm Arzneimittel GmbH
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
Ozurdex 700Mikrogramm Implantat 1Stk
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松
生产厂家英文名:
Emra-Med Arzneimittel GmbH 
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
Ozurdex 700Mikrogramm Implantat 1Stk
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松
生产厂家英文名:
kohlpharma GmbH 
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
Ozurdex 700Mikrogramm Implantat 1Stk
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松
生产厂家英文名:
Orifarm GmbH
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
Ozurdex 700Mikrogramm Implantat 1Stk
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松
生产厂家英文名:
Abacus Medicine A/S
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
Ozurdex 700Mikrogramm Implantat 1Stk
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松 
生产厂家英文名:
Cc-Pharma GmbH
--------------------------------------------------------
产地国家:德国
原产地英文商品名:
Ozurdex 700 Mikrogramm Implantat 1Stk
原产地英文药品名:
Dexamethasone
中文参考商品译名:
Ozurdex植入物 700微克 1套件
中文参考药品译名:
地塞米松
生产厂家英文名:
Haemato Pharm GmbH

责任编辑:p53


相关文章
美国FDA批准Ozurdex植入物用于成年糖尿病黄斑水肿患者
DECADRON Tablets(地塞米松片)
LenaDex Tablets(Dexamethasone)
Erizas Capsule for Nasal spray(地塞米松胶囊喷鼻剂)
地塞米松片(DEXAMETHASONE Tablets)
Limethason INTRAVENOUS INJECTION 2.5mg(地塞米松棕榈酸酯脂注射剂)
dexamethasone cipecilate(Erizas)|吸入式皮质类固醇药物
FDA推荐雷珠单抗治疗糖尿病黄斑水肿
OZURDEX intravitreal implant(地塞米松玻璃体内植入物)
 

最新文章

更多

· Ozurdex implant(地塞米...
· EYLEA solution for IVT...
· LUCENTIS solution Inje...
· LUCENTIS kit injection...
· JETREA(OCRIPLASMIN)注...
· JETREA(ocriplasmin)玻璃...
· Visudyne(Verteporfin ...
· Visudyne(Verteporfin i...
· Eylea(阿柏西普注射剂,...
· 兰尼单抗注射剂|Lucenti...

推荐文章

更多

· Ozurdex implant(地塞米...
· EYLEA solution for IVT...
· LUCENTIS solution Inje...
· LUCENTIS kit injection...
· JETREA(OCRIPLASMIN)注...
· JETREA(ocriplasmin)玻璃...
· Visudyne(Verteporfin ...
· Visudyne(Verteporfin i...
· Eylea(阿柏西普注射剂,...
· 兰尼单抗注射剂|Lucenti...

热点文章

更多

· Ozurdex implant(地塞米...